Format

Send to

Choose Destination
Ann Oncol. 2018 Sep 1;29(9):2018. doi: 10.1093/annonc/mdy238.

Reply to the letter to the editor 'Anti-EGFR therapy in oesophagogastric cancer: precise but not enough' by M. Salati and S. Cascinu.

Author information

1
Department of Oncology and Haematology, Cantonal Hospital of St. Gallen, St. Gallen.
2
Institute of Pathology, University Hospital of Berne, Berne, Switzerland.
3
Department of Haematology, Oncology and Tumorimmunology, University Medicine, Berlin, Germany.
4
Medical Department, Medical University, Innsbruck, Austria.
5
Medical Oncology, Kliniken Essen-Mitte, Essen, Germany.
PMID:
29992287
DOI:
10.1093/annonc/mdy238
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center